FIELD: medicine.
SUBSTANCE: low-intensity laser with wave 630 nm and power 50 mcW/cm2 is applied daily with course of 15 days. For external application: the nose bridge is exposed for 1 min, central part of dorsum of nose - for 20 sec, in point of fossa canina on both sides - for 1 min. Intranasal application - the light guide is inserted 1 cm into both nasal meati alternately, exposure time - 15 sec. Blood is exposed transcutaneously by 15 min exposure of the area above the ulnar vena. Simultaneously with the laser therapy course, the patient is administered intranasally the combined inhaler Seretid, which contains Salmeterol (25 mcg) and Fluticazone propionate (125 mcg), during inspiration, into each nasal meatus, twice a day.
EFFECT: method increases therapeutic efficiency and provides rapid regression of polypous tissue.
1 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING BRONCHIAL ASTHMA PATIENTS FOR POLYPOUS RHINOSINUSITES | 2002 |
|
RU2229317C2 |
| METHOD OF POLYPOUS RHINOSINUSITIS TREATMENT | 2006 |
|
RU2329059C1 |
| MUCOLYTIC COLLECTION FOR THE TREATMENT OF RHINOSINUSITIS POLYPOSA | 2021 |
|
RU2762350C1 |
| METHOD FOR EVALUATING EFFICACY OF DRUG-INDUCED THERAPY OF POLYPOUS RHINOSINUSITIS | 2010 |
|
RU2428695C1 |
| USE OF PREPARATION CONTAINING AMMONIUM GLYCYRRHIZINATE AS ACTIVE INGREDIENT IN ANTI-INFLAMMATORY THERAPY OF POLYPOUS RHINOSINUSITIS | 2023 |
|
RU2817652C1 |
| METHOD FOR PHENOTYPE DETERMINATION OF CHRONIC INFLAMMATORY DISEASES OF NOSE AND PARANASAL SINUSES IN CASE OF INDICATIONS FOR TARGETED THERAPY | 2023 |
|
RU2826780C1 |
| METHOD OF TREATING CHRONIC RECURRING INFLAMMATORY DISEASES OF NASAL CAVITY AND PARANASAL SINISES BY METHOD OF ENDONASAL AUTOLYMPHOCYTO THERAPY | 2009 |
|
RU2403071C1 |
| METHOD OF TREATING CHRONIC RHINOSINUSITIS | 2011 |
|
RU2469737C1 |
| METHOD FOR LASER PHORESIS IN TREATING CHRONIC RHINOSINUSITIS POLYPOSA | 2014 |
|
RU2566211C1 |
| METHOD FOR TREATING CHRONIC POLYPOUS RHINOSINUSITIS | 2000 |
|
RU2163097C1 |
